News MHRA authorizes the use of Pfizer/Biontech COVID-19 vaccine in kids aged 6 months to 4 years By December 6, 202230 views ShareTweet 0 Authorization has today been granted for a new presentation of the Pfizer/BioNTech COVID-19 vaccine (Comirnaty) for use in infants and children aged 6 months to 4 years.
Study highlights need for regular home and doctor’s blood pressure measurements for white-coat syndrome By 13 mins ago0
Early life adversity linked to accelerated neurobiological aging, raising vulnerability to depression and Alzheimer’s By 1 hour ago0
Music therapy proves effective in treating depression for ADHD in children and adolescents By 2 hours ago0
Common amino acid discovery improves understanding of the biological causes of depression 4 hours ago0
Certain T cells in human blood produce acetylcholine that regulates blood pressure and inflammation 4 hours ago0
$3.2 million grant aids in the study of genetic testing approach to close racial disparity gaps in cancer care 6 hours ago0
By 
Comments